Experts don't back specific tests, but provide guidelines on how doctors in specialty care settings can use them to diagnose ...

The partners will seek CAP/CLIA certification for an organoid-based assay and conduct clinical validation studies of it as a tool to guide treatment.

NEW YORK – ARTBio this week said it has raised $132 million in Series B financing to advance its alpha radioligand therapies and bolster the supply chain underlying their development.

The agency previously declined to approve Atara's first Ebvallo biologics license application, but has accepted a data package it resubmitted this month.